Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative by Rania Abdel-latif (18295396)

“…Actionable CYP2C19 alleles were detected in 22% of those patients, prompting a change in drug therapy. PGx-guided recommendations were adopted at a rate of 80%, and CYP2C19 genotyping was a significant predictor of antiplatelet therapy adjustments. …”

Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance by Gh Rasool Bhat (13038132)

“…This diversity, known as cancer cell plasticity, confers cancer cells the ability to change in response to their environment, leading to increased tumor diversity and drug resistance. …”

Modeling of tri-parameter contracts integrating cost, time and risk by Rabie, Mohamad M.

Get full text

Mortality patterns in older adults with infective endocarditis in the US: A retrospective analysis by Hamza Ashraf (20726490)

“…<h3>Background</h3><p dir="ltr">Infective Endocarditis (IE) has become a significant cause of morbidity and mortality over the last two decades. …”

Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: A systematic review and meta-analysis by Myriam Jaam (11014409)

“…They are widespread in healthcare systems and are linked to an increased risk of morbidity and mortality. Several strategies have been studied to reduce their occurrence including different types of pharmacy-based interventions. …”